Literature DB >> 122286

Sustained elevation of serum prolactin by metoclopramide: a clinical model of idiopathic hyperprolactinemia.

D L Healy, H G Burger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 122286     DOI： 10.1210/jcem-46-5-709

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  Hyperprolactinemia: neuroendocrine and diagnostic aspects.

Authors:  F Camanni; E Ciccarelli; E Ghigo; E E Müller
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

2.  Metoclopramide-induced reversible impotence.

Authors:  R G Berlin
Journal:  West J Med       Date:  1986-03

3.  Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.

Authors:  R M Carey; M O Thorner; E M Ortt
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

Review 4.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

5.  Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models.

Authors:  M Stanley; A Lautin; J Rotrosen; S Gershon; D Kleinberg
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.